# Lifitegrast

NDC: 59651-450
Generic name: Lifitegrast
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: FOR SOLUTION
Routes: OPHTHALMIC
Marketing started: 20231107

FDA application: ANDA215063

## Active ingredients

- LIFITEGRAST: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-450"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-450
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d4b4b61-79da-4b6f-bb19-056d111bf400